Decision-making in priority setting for medicines--a review of empirical studies.
about
HOSPITAL MANAGERS' NEED FOR INFORMATION ON HEALTH TECHNOLOGY INVESTMENTSEvidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.Decision-making in healthcare: a practical application of partial least square path modelling to coverage of newborn screening programmes.Public engagement in health priority setting in low- and middle-income countries: current trends and considerations for policyField testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa.Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness frameworkFrom efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmakingThe role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi ArabiaStated and Revealed Preferences for Funding New High-Cost Cancer Drugs: A Critical Review of the Evidence from Patients, the Public and Payers.The use (or rather the non-use) of cost-effectiveness data in priority setting decisions - are we underestimating the barriers to using health economics in real world priority setting decisions?: Comment on "Use of cost-effectiveness data in prioritSimilarities and differences between five European drug reimbursement systems.Public funding of pharmaceuticals in The Netherlands: investigating the effect of evidence, process and context on CVZ decision-making.Decision making by NICE: examining the influences of evidence, process and context.Revealed and Stated Preferences of Decision Makers for Priority Setting in Health Technology Assessment: A Systematic Review.Social preferences for the inclusion of indirect benefits in the evaluation of publicly funded health services: results from an Australian survey.Study design and the estimation of the size of key populations at risk of HIV: lessons from Viet Nam.Cost-effectiveness of nanomedicine: the path to a future successful and dominant market?Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.Attitudes and barriers toward mini-HTA in the Danish municipalities.Contextual Factors Influencing Cost and Quality Decisions in Health and Care: A Structured Evidence Review and Narrative SynthesisWhat is a priority?
P2860
Q28072358-E230814F-C4CA-40EA-A57F-2CDCF97FA140Q33395099-1E1B80B0-C9F9-479D-95D1-7CDCC5E24BB1Q34362510-E849765B-1FD1-4BC2-ADF3-0608096A5856Q34934241-74CB4044-A609-49CD-A744-5A27B9738701Q35898829-FAD1673D-34CE-46FC-A079-28AFCE5F1D55Q35951057-91E1511E-DF48-4A54-92C9-BE1FCCB29F82Q36390478-5B9659B6-F175-4EB1-9D54-1F5DA099E2E7Q37098743-60DE6F06-71F7-470E-A393-E3F94242C9D2Q38586798-4E526257-E0D6-4A18-A136-357466ED4644Q41213704-CE2327DD-1BAC-45F3-BE4B-DDD284670D94Q42668677-B88C2871-9889-4B81-81EF-F39102089430Q43620093-7E4232C5-F7E7-4500-B3E0-C7001CB03F4EQ43874762-755F6A24-5DBC-48EA-91F1-E8D7991934EDQ47220948-F4578AEA-4B6B-4CE4-BC8D-38E12F4F180DQ47579991-B27C0221-6322-4FEB-A954-B7E8DC3AC538Q47703833-73C416C8-A8C2-407B-B3FD-08A000D28882Q48443740-87A88100-E31C-4909-8CBC-F04EAF874A6EQ48572824-148420C9-646D-4EDC-8387-34616A1C4705Q50557222-849F9B1F-F61D-4122-BE97-E586090D0B5CQ57132787-065B58B5-A480-4425-9495-E9C8B9C5C136Q57559781-91EB94CC-F64C-4D92-BFD6-852A7B0C386B
P2860
Decision-making in priority setting for medicines--a review of empirical studies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Decision-making in priority setting for medicines--a review of empirical studies.
@en
type
label
Decision-making in priority setting for medicines--a review of empirical studies.
@en
prefLabel
Decision-making in priority setting for medicines--a review of empirical studies.
@en
P2093
P1433
P1476
Decision-making in priority setting for medicines--a review of empirical studies.
@en
P2093
Elina Hemminki
Hanna Toiviainen
Lauri Vuorenkoski
P356
10.1016/J.HEALTHPOL.2007.09.007
P577
2007-10-22T00:00:00Z